Sign In
Buy HAE
$65.88
-0.490 (-0.738%)
At Close: Jun 03, 2026
Haemonetics to Present at Goldman Sachs 47th Annual Global Healthcare Conference
04:05pm, Tuesday, 02'nd Jun 2026
BOSTON, June 2, 2026 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that Chris Simon, President and CEO, will participate in a fireside chat with investors at the Goldman Sachs 47th An
[url="]KalVista Pharmaceuticals[/url], Inc. (Nasdaq: KALV) today announced new data highlighting the burden of injectable on-demand treatment in children aged
RESEARCH TRIANGLE PARK, N.C., May 27, 2026 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company will present seven abstracts from its hereditary angioede
Investing in Haemonetics (HAE)? Don't Miss Assessing Its International Revenue Trends
10:15am, Friday, 22'nd May 2026
Examine the evolution of Haemonetics' (HAE) overseas revenue trends and their effects on Wall Street's forecasts and the stock's prospects.
Is It Too Late to Buy Haemonetics Corp (HAE) After 4.0% Rally? GF Value Says Undervalued
08:21pm, Thursday, 21'st May 2026
On May 21, 2026, Haemonetics Corp (HAE) shares rose 4.0%, bringing the current price to $61.94. The stock has fluctuated significantly over the past year, with
Is the Options Market Predicting a Spike in Haemonetics Stock?
10:25am, Wednesday, 13'th May 2026
Investors need to pay close attention to GBTG stock based on the movements in the options market lately.
Haemonetics Corporation (HAE) Presents at Bank of America Global Healthcare Conference 2026 Transcript
01:20pm, Tuesday, 12'th May 2026
Haemonetics Corporation (HAE) Presents at Bank of America Global Healthcare Conference 2026 Transcript
HAE Stock Gains on Q4 Earnings & Revenue Beat, Gross Margin Cut
03:26pm, Monday, 11'th May 2026
Haemonetics beats Q4 EPS and revenue estimates, shares rise 1.4%, but gross margin falls 120 basis points as the company sets its FY27 growth outlook.
Haemonetics Q4 Earnings Call Highlights
03:05pm, Sunday, 10'th May 2026
Haemonetics NYSE: HAE reported fiscal fourth-quarter revenue of $346 million, up 5% on a reported basis and 9% organically excluding CSL, as strength in its Plasma and Blood Management Technologies bu
The London Company Small Cap Portfolio Q1 2026 Portfolio Review
05:11am, Friday, 08'th May 2026
Matson was the top performer as container shipping rates strengthened amid supply chain disruptions and management executed on operational efficiency initiatives. Revolve Group sold off as the online
Haemonetics Corporation (HAE) Q4 2026 Earnings Call Transcript
02:41am, Friday, 08'th May 2026
Haemonetics Corporation (HAE) Q4 2026 Earnings Call Transcript
Haemonetics (HAE) Reports Q4 Earnings: What Key Metrics Have to Say
10:36am, Thursday, 07'th May 2026
Although the revenue and EPS for Haemonetics (HAE) give a sense of how its business performed in the quarter ended March 2026, it might be worth considering how some key metrics compare with Wall Stre
Haemonetics (HAE) Q4 Earnings and Revenues Surpass Estimates
08:10am, Thursday, 07'th May 2026
Haemonetics (HAE) came out with quarterly earnings of $1.29 per share, beating the Zacks Consensus Estimate of $1.28 per share. This compares to earnings of $1.24 per share a year ago.
Haemonetics Corporation Announces Fourth Quarter Fiscal 2026 Financial Results Available on Investor Relations Website
06:00am, Thursday, 07'th May 2026
Financial release and supplemental presentation accessible online BOSTON, May 7, 2026 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that financial results for its fourth quarter fisca
Haemonetics to Present at Bank of America 2026 Healthcare Conference
06:00am, Tuesday, 05'th May 2026
BOSTON, May 5, 2026 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that Chris Simon, President and CEO, will participate in a fireside chat with investors at the Bank of America 2026 He
